Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1961 1
1962 1
1965 1
1966 1
1967 1
1968 1
1969 2
1985 1
1986 1
1992 1
1993 1
1995 1
1996 1
1997 1
1998 1
2000 2
2002 1
2003 1
2004 3
2005 3
2006 2
2008 2
2009 1
2010 4
2011 1
2012 2
2013 1
2014 1
2015 1
2016 1
2017 2
2018 2
2019 2
2020 2
2021 3
2022 2
2023 1
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases.
Angeletti A, Bin S, Kajana X, Spinelli S, Bigatti C, Caridi G, Candiano G, Lugani F, Verrina EE, La Porta E, Magnasco A, Bruschi M, Cravedi P, Ghiggeri GM. Angeletti A, et al. Among authors: magnasco a. Kidney Int Rep. 2024 Apr 4;9(6):1892-1896. doi: 10.1016/j.ekir.2024.04.006. eCollection 2024 Jun. Kidney Int Rep. 2024. PMID: 38899172 Free PMC article. No abstract available.
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G; Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi. Iatropoulos P, et al. J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13. J Am Soc Nephrol. 2018. PMID: 29030465 Free PMC article.
Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three Cases.
Volpi S, Angelotti ML, Palazzini G, Antonelli G, Ravaglia F, Garibotto F, Agrusti A, Grossi A, Magnasco A, Rossi GM, Errichiello C, Peyronel F, Buti E, Lodi L, Ghiggeri GM, Romagnani P, Vaglio A. Volpi S, et al. Among authors: magnasco a. Am J Kidney Dis. 2024 Dec;84(6):791-797. doi: 10.1053/j.ajkd.2024.05.014. Epub 2024 Jul 24. Am J Kidney Dis. 2024. PMID: 39059688
[Hemodialysis access recirculation].
Alloatti S, Magnasco A, Manes M, Bonfant G. Alloatti S, et al. Among authors: magnasco a. G Ital Nefrol. 2004 Sep-Oct;21(5):438-45. G Ital Nefrol. 2004. PMID: 15547875 Review. Italian.
Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.
Chan RWY, Serpas L, Ni M, Volpi S, Hiraki LT, Tam LS, Rashidfarrokhi A, Wong PCH, Tam LHP, Wang Y, Jiang P, Cheng ASH, Peng W, Han DSC, Tse PPP, Lau PK, Lee WS, Magnasco A, Buti E, Sisirak V, AlMutairi N, Chan KCA, Chiu RWK, Reizis B, Lo YMD. Chan RWY, et al. Among authors: magnasco a. Am J Hum Genet. 2025 May 1;112(5):1247. doi: 10.1016/j.ajhg.2025.04.001. Am J Hum Genet. 2025. PMID: 40315821 Free PMC article. No abstract available.
57 results